A recent study, published in Drug Safety, aimed to describe the adverse drug reactions reported in inflammatory bowel disease patients […]
A recent article proposed the mining of knowledge graphs to identify biomolecular adverse drug reaction mechanisms, which at present largely […]
Drug-induced liver injury is a common reason for the withdrawal of a drug from the market. Therefore, early assessment of […]
Computationally predicting molecular shapes and structures plays an important role in drug discovery, as it enables the identification of drug […]
Researchers have constructed a tumour-biomarker knowledge graph and used it to discover potential adverse drug reactions from antitumour drugs. Adverse […]
A recent study aimed to assess the safety of intravitreal ranibizumab biosimilar molecule (Razumab) treatment for chorioretinal diseases under real-world […]
We summarise a recent study that used real-world data (RWD) to explore the prevalence of adverse effects in patients before […]
We summarise a recent article, published in Drug Discovery Today, that summarised how the increasing volume and availability of data […]
“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]
Electronic health records (EHRs) are receiving growing attention as a potential source of real-world data. However, their suitability for evaluating […]
